Roche builds strength in molecular diagnostics

Roche has scooped up DNA sequencing firm Genia Technologies, reports the Wall Street Journal. The deal includes $125 million in an upfront payment, and the WSJ notes Monday's deal synchs with its acquisition of the molecular diagnostics firm IQuum and Roche's efforts to bolster its standing in this diagnostics space.

Roche attempted a hostile takeover of San Diego-based DNA sequencing firm Illumina in 2012. Illumina CEO Jay Flatley rallied stockholders to reject the takeover.

You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.